{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:34:29Z","timestamp":1792668869438,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hoc.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:37:34Z","timestamp":1628725054000},"page":"1103-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Acquired von Willebrand Syndrome"],"prefix":"10.1016","volume":"35","author":[{"given":"Arielle L.","family":"Langer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan T.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJM195807242590416","article-title":"Gastrointestinal bleeding in aortic stenosis","volume":"259","author":"Heyde","year":"1958","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0002-9610(86)90465-4","article-title":"Colonic vascular ectasias and aortic stenosis: coincidence or causal relationship?","volume":"151","author":"Greenstein","year":"1986","journal-title":"Am J Surg"},{"issue":"22","key":"10.1016\/j.hoc.2021.07.005_bib3","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJM198605293142202","article-title":"Treatment with desmopressin acetate to reduce blood loss after cardiac surgery","volume":"314","author":"Salzman","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"8810","key":"10.1016\/j.hoc.2021.07.005_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0140-6736(92)92434-H","article-title":"Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?","volume":"340","author":"Warkentin","year":"1992","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib5","first-page":"345","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"issue":"25","key":"10.1016\/j.hoc.2021.07.005_bib6","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis","volume":"63","author":"Fabris","year":"1986","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2021.07.005_bib8","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/cancers12071746","article-title":"Essential thrombocythemia and acquired von Willebrand syndrome: the shadowlands between thrombosis and bleeding","volume":"12","author":"Awada","year":"2020","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.hoc.2021.07.005_bib9","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2011-11-388256","article-title":"Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia","volume":"120","author":"Hivert","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.jvca.2020.06.083","article-title":"Von Willebrand factor concentrate administration for acquired von Willebrand syndrome-related bleeding during adult extracorporeal membrane oxygenation","volume":"35","author":"Mazzeffi","year":"2020","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5551\/jat.27268","article-title":"Early diagnosis of acquired von Willebrand syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy","volume":"22","author":"Kalbhenn","year":"2015","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2002-27824","article-title":"Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry","volume":"28","author":"Budde","year":"2002","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1538-7836.2008.02909.x","article-title":"Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study","volume":"6","author":"Tiede","year":"2008","journal-title":"J\u00a0Thromb Haemost JTH"},{"issue":"13","key":"10.1016\/j.hoc.2021.07.005_bib14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.005_bib15","first-page":"396","article-title":"The evolving epidemiology of valvular aortic stenosis. The Troms\u00f8 study","volume":"99","author":"Eveborn","year":"2013","journal-title":"Heart Br Card Soc"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00134-011-2370-6","article-title":"Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS)","volume":"38","author":"Heilmann","year":"2012","journal-title":"Intensive Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2021.07.005_bib18","first-page":"45","article-title":"Acquired von Willebrand syndrome in respiratory extracorporeal life support: a systematic review of the literature","volume":"19","author":"Malfertheiner","year":"2017","journal-title":"Crit Care Resusc J Australas Acad Crit Care Med"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/a-1150-2016","article-title":"Acquired von Willebrand syndrome and platelet function defects during extracorporeal life support (mechanical circulatory support)","volume":"40","author":"Schlagenhauf","year":"2020","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.hoc.2021.07.005_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2019.00007","article-title":"Acquired von Willebrand syndrome in patients with ventricular assist device","volume":"6","author":"Rauch","year":"2019","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12928-019-00568-y","article-title":"Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation","volume":"34","author":"Tamura","year":"2019","journal-title":"Cardiovasc Interv Ther"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1213\/ANE.0000000000000554","article-title":"Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers","volume":"120","author":"Tauber","year":"2015","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejcts.2007.12.047","article-title":"Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease","volume":"33","author":"Geisen","year":"2008","journal-title":"Eur J Cardio-thorac Surg"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.005_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/ATVBAHA.116.308524","article-title":"Plasmin cleaves von Willebrand factor at K1491-R1492 in the A1-A2 linker region in a shear- and glycan-dependent manner in\u00a0vitro","volume":"37","author":"Brophy","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjcard.2012.10.015","article-title":"Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study)","volume":"111","author":"Blackshear","year":"2013","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.hoc.2021.07.005_bib27","first-page":"2023","article-title":"Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis","volume":"97","author":"Natorska","year":"2011","journal-title":"Heart Br Card Soc"},{"issue":"10","key":"10.1016\/j.hoc.2021.07.005_bib28","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.5551\/jat.34421","article-title":"Rapid restoration of thrombus formation and high-molecular-weight von Willebrand factor multimers in patients with severe aortic stenosis after valve replacement","volume":"23","author":"Yamashita","year":"2016","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5551\/jat.RV17031","article-title":"Acquired von Willebrand syndrome associated with cardiovascular diseases","volume":"26","author":"Horiuchi","year":"2019","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4065\/mcp.2010.0309","article-title":"Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy","volume":"86","author":"Blackshear","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib31","first-page":"112","article-title":"A\u00a0case of hypertrophic obstructive cardiomyopathy and acquired von Willebrand syndrome: response to medical therapy","volume":"12","author":"Wake","year":"2014","journal-title":"J\u00a0Echocardiogr"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.005_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2011.08732.x","article-title":"Acquired von Willebrand syndrome in congenital heart disease: does it promote an increased bleeding risk?","volume":"155","author":"Onimoe","year":"2011","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijcard.2014.07.104","article-title":"Acquired von Willebrand syndrome in adult patients with congenital heart disease","volume":"176","author":"Waldow","year":"2014","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.005_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/icvts\/ivu305","article-title":"Shear-stress induced acquired von Willebrand syndrome in children with congenital heart disease","volume":"19","author":"Loeffelbein","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"12","key":"10.1016\/j.hoc.2021.07.005_bib35","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.12734","article-title":"Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation","volume":"12","author":"Blackshear","year":"2014","journal-title":"J\u00a0Thromb Haemost JTH"},{"issue":"9","key":"10.1016\/j.hoc.2021.07.005_bib36","first-page":"1108.e9-10","article-title":"Acquired Von Willebrand syndrome secondary to mitral and aortic regurgitation","volume":"30","author":"Wan","year":"2014","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.hoc.2021.07.005_bib37","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/jocs.14796","article-title":"Acquired von Willebrand syndrome secondary to mitral and aortic regurgitation","volume":"35","author":"Kasai","year":"2020","journal-title":"J\u00a0Card Surg"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchf.2013.10.008","article-title":"Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device","volume":"2","author":"Meyer","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"15","key":"10.1016\/j.hoc.2021.07.005_bib39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.005_bib40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCHEARTFAILURE.109.877597","article-title":"Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device","volume":"3","author":"Meyer","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/jth.13933","article-title":"Acquired coagulopathy in patients with left ventricular assist devices","volume":"16","author":"Muslem","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hoc.2021.07.005_bib42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib43","first-page":"357","article-title":"European results with a continuous-flow ventricular assist device for advanced heart-failure patients","volume":"37","author":"Lahpor","year":"2010","journal-title":"Eur J Cardio-thorac Surg"},{"issue":"19","key":"10.1016\/j.hoc.2021.07.005_bib44","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.jacc.2010.10.062","volume":"57","author":"Starling","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.gie.2014.03.040","article-title":"GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis","volume":"80","author":"Draper","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib46","first-page":"849","article-title":"Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device","volume":"30","author":"Demirozu","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib47","doi-asserted-by":"crossref","first-page":"e0183193","DOI":"10.1371\/journal.pone.0183193","article-title":"Acquired von Willebrand syndrome in cardiogenic shock patients on mechanical circulatory microaxial pump support","volume":"12","author":"Flierl","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1051\/ject\/201850077","article-title":"High molecular weight von Willebrand factor multimer loss and bleeding in patients with short-term mechanical circulatory support devices: a case series","volume":"50","author":"Goldfarb","year":"2018","journal-title":"J\u00a0Extra Corpor Technol"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MAT.0000000000000069","article-title":"Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device","volume":"60","author":"Davis","year":"2014","journal-title":"ASAIO J"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.healun.2018.03.013","article-title":"Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: rapid onset and fast recovery","volume":"37","author":"Kalbhenn","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.hoc.2021.07.005_bib51","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib52","first-page":"123","article-title":"Acquired type 2A von Willebrand disease in chronic myelocytic leukemia","volume":"10","author":"Mohri","year":"1996","journal-title":"Hematopathol Mol Hematol"},{"issue":"1 Suppl 1","key":"10.1016\/j.hoc.2021.07.005_bib53","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/j.seminhematol.2005.11.003","article-title":"Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders","volume":"43","author":"Federici","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2021.07.005_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2016.11.011","article-title":"Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera","volume":"41","author":"Rottenstreich","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.hoc.2021.07.005_bib55","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2006-05-025544","article-title":"Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?","volume":"108","author":"Tefferi","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2021.07.005_bib56","doi-asserted-by":"crossref","first-page":"914","DOI":"10.20452\/pamw.3211","article-title":"Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients","volume":"125","author":"Mital","year":"2015","journal-title":"Pol Arch Med Wewn"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib57","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.thromres.2015.07.029","article-title":"Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera: retrospective analysis of 142 consecutive cases","volume":"136","author":"Mital","year":"2015","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib58","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.005_bib59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00277-016-2650-x","article-title":"Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias","volume":"95","author":"Dicke","year":"2016","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib60","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MBC.0000000000000600","article-title":"Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis","volume":"28","author":"Harrison","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.005_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.20829","article-title":"Association of acquired von Willebrand syndrome with AL amyloidosis","volume":"82","author":"Kos","year":"2007","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib62","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/hae.13626","article-title":"Severe acquired von Willebrand syndrome secondary to systemic lupus erythematosus","volume":"25","author":"Stufano","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.hoc.2021.07.005_bib63","article-title":"Characteristics of acquired inhibitors to factor VIII and von Willebrand factor secondary to systemic lupus erythematosus: experiences from a Chinese tertiary medical center","author":"Cao","year":"2019","journal-title":"J\u00a0Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"10.1016\/j.hoc.2021.07.005_bib64","first-page":"208597","article-title":"Acquired von Willebrand's syndrome in systemic lupus erythematosus","volume":"2014","author":"Taveras Alam","year":"2014","journal-title":"Case Rep Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.transci.2017.04.006","article-title":"A\u00a0case of autoimmune severe acquired von Willebrand syndrome (type 3-like)","volume":"56","author":"Gavva","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.hoc.2021.07.005_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2162-3619-3-21","article-title":"Acquired hemophilia A and von Willebrand syndrome in a patient with late-onset systemic lupus erythematosus","volume":"3","author":"Dicke","year":"2014","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.1999.01360.x","article-title":"Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus","volume":"105","author":"Viallard","year":"1999","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.hoc.2021.07.005_bib68","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0961203308089429","article-title":"Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome","volume":"17","author":"Hong","year":"2008","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00001721-200206000-00013","article-title":"Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus","volume":"13","author":"Niiya","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.hoc.2021.07.005_bib70","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1752-1947-7-232","article-title":"Pulmonary hypertension secondary to hyperviscosity in a patient with rheumatoid arthritis and acquired von Willebrand disease: a case report","volume":"7","author":"Hern\u00e1ndez-Gilsoul","year":"2013","journal-title":"J\u00a0Med Case Rep"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib71","first-page":"211","article-title":"[Report of 2 cases with acquired von Willebrand disease and one with acquired hemophilia A]","volume":"47","author":"Mart\u00ednez-Murillo","year":"1995","journal-title":"Rev Investig Clin Organo Hosp Enfermedades Nutr"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib72","first-page":"211","article-title":"Acquired von Willebrand's disease following bone marrow transplantation","volume":"24","author":"Lazarchick","year":"1994","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib73","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1971.tb03429.x","article-title":"Four cases of acquired von Willebrand's syndrome","volume":"21","author":"Ingram","year":"1971","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<151::AID-AJH13>3.0.CO;2-J","article-title":"Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor","volume":"60","author":"Alhumood","year":"1999","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.1992.10.3.422","article-title":"Acquired von Willebrand disease in Wilms' tumor patients","volume":"10","author":"Coppes","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"issue":"6 Pt 1","key":"10.1016\/j.hoc.2021.07.005_bib76","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3476(05)82007-4","article-title":"Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy","volume":"125","author":"Bruggers","year":"1994","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib77","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2516.2002.00589.x","article-title":"Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery","volume":"8","author":"Franchini","year":"2002","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/107602960100700206","article-title":"Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine","volume":"7","author":"Michiels","year":"2001","journal-title":"Clin Appl Thromb"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib79","first-page":"143","article-title":"Acquired von Willebrand's disease, IgE polyclonal gammopathy and griseofulvin therapy","volume":"41","author":"Conrad","year":"1992","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.2830490114","article-title":"Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor","volume":"49","author":"Castaman","year":"1995","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/088307380201700110","article-title":"Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid","volume":"17","author":"Serdaroglu","year":"2002","journal-title":"J\u00a0Child Neurol"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib82","first-page":"306","article-title":"The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity","volume":"25","author":"Lazarchick","year":"1995","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib83","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2257.1992.tb00367.x","article-title":"Hydroxyethyl starch induced acquired von Willebrand's disease","volume":"14","author":"Dalrymple-Hay","year":"1992","journal-title":"Clin Lab Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib84","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJM200108233450818","article-title":"Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch","volume":"345","author":"Jonville-B\u00e9ra","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/rth2.12468","article-title":"Sexism in the management of bleeding disorders","volume":"5","author":"Weyand","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"10.1016\/j.hoc.2021.07.005_bib86","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"issue":"suppl","key":"10.1016\/j.hoc.2021.07.005_bib87","first-page":"196a","article-title":"The von Willebrand factor propolypeptide, von Willebrand antigen II (vWAgII), distinguishes acquired von Willebrand syndrome (AvWS) due to decreased synthesis of von Willebrand factor (vWF) from AvWS due to increased clearance of vWF [abstract]","volume":"86","author":"Scott","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib88","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","article-title":"von Willebrand factor regulation of blood vessel formation","volume":"132","author":"Randi","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib89","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2021.07.005_bib90","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0049-3848(16)30366-8","article-title":"Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia","volume":"141","author":"Randi","year":"2016","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.005_bib91","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/bjh.15200","article-title":"Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenstr\u00f6m macroglobulinaemia","volume":"184","author":"Castillo","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib92","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2021.07.005_bib93","author":"Abou-Ismail"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib94","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V64.3.614.614","article-title":"Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies","volume":"64","author":"Mannucci","year":"1984","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MBC.0b013e3280100d1e","article-title":"The use of recombinant activated factor VII in congenital and acquired von Willebrand disease","volume":"17","author":"Franchini","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.005_bib96","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/trf.12017","article-title":"Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose scheduling","volume":"53","author":"Kanakry","year":"2013","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib97","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/flgastro-2018-101116","article-title":"Rituximab to the rescue: novel therapy for chronic gastrointestinal bleeding due to angiodysplasia and acquired von Willebrand syndrome","volume":"10","author":"Hawken","year":"2019","journal-title":"Frontline Gastroenterol"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib98","first-page":"420","article-title":"[Durable remission attained with rituximab therapy in a patient with acquired von Willebrand syndrome associated with CD20-positive lymphoproliferative disorder]","volume":"59","author":"Kurahashi","year":"2018","journal-title":"Rinsho Ketsueki"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.005_bib99","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11239-008-0195-0","article-title":"A\u00a0case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab","volume":"27","author":"Pasa","year":"2009","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.hoc.2021.07.005_bib100","first-page":"9295780","article-title":"Acquired von Willebrand disease associated with monoclonal gammopathy of unknown significance","volume":"2017","author":"Basnet","year":"2017","journal-title":"Case Rep Oncol Med"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib101","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1160\/TH07-07-0456","article-title":"Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome","volume":"99","author":"Grimaldi","year":"2008","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.005_bib102","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ajh.21692","article-title":"Bortezomib effectiveness in one patient with acquired von Willebrand syndrome associated to monoclonal gammopathy of undetermined significance","volume":"85","author":"Ojeda-Uribe","year":"2010","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MAT.0000000000000143","article-title":"Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices","volume":"61","author":"Loyaga-Rendon","year":"2015","journal-title":"ASAIO J"},{"issue":"11","key":"10.1016\/j.hoc.2021.07.005_bib104","doi-asserted-by":"crossref","first-page":"e004500","DOI":"10.1161\/CIRCHEARTFAILURE.117.004500","article-title":"Multicenter evaluation of octreotide as secondary prophylaxis in patients with left ventricular assist devices and gastrointestinal bleeding","volume":"10","author":"Shah","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.005_bib105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MAT.0000000000000491","article-title":"Tolerability and biological effects of long-acting octreotide in patients with continuous flow left ventricular assist devices","volume":"63","author":"Malhotra","year":"2017","journal-title":"ASAIO J"},{"issue":"9","key":"10.1016\/j.hoc.2021.07.005_bib106","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1525-1594.2010.01084.x","article-title":"Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience","volume":"34","author":"Hayes","year":"2010","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.005_bib107","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.healun.2014.09.013","article-title":"Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol","volume":"34","author":"Draper","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.005_bib108","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MAT.0000000000000087","article-title":"Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide","volume":"60","author":"Ray","year":"2014","journal-title":"ASAIO J"},{"issue":"11","key":"10.1016\/j.hoc.2021.07.005_bib109","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5301\/ijao.5000620","article-title":"Novel use of low-dose thalidomide in refractory gastrointestinal bleeding in left ventricular assist device patients","volume":"40","author":"Seng","year":"2017","journal-title":"Int J Artif Organs"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:17:51Z","timestamp":1760185071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858821000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":109,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0889858821000848"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.07.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired von Willebrand Syndrome","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}